Cite

HARVARD Citation

    Fisher, A. et al. (2020). Sodium‐glucose co‐transporter‐2 inhibitors and the risk of urosepsis: A multi‐site, prevalent new‐user cohort study. Diabetes, obesity & metabolism. 22 (9), pp. 1648-1658. [Online]. 
  
Back to record